A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 187,500 shares at $10.37 ($1.9M) on 2016-06-06, disclosed to the SEC on 2016-06-07.
Open-market sale of $1.9M TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |